Naari Pharma Private Limited
FDA inspection history in Rudrapur, India, 2023
- 1
- Form 483
Every document, by year
- Form 483
2023: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2023One Form 483, at Rudrapur, India.
Cited most
Across all Naari Pharma Private Limited observations on file
- 21 CFR 211.100Written procedures; deviations2
The complete Naari Pharma Private Limited file.
All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.
Sites
Rudrapur, India
One Form 483 · 2023 · 2 observations
Latest: Form 483, Jan 27, 2023 →
Documents
1 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2023-01-27 | 483 Form 483 | Rudrapur, India | 2 | $99 |
Investigators on these documents
FEI number 3014247908 · most recent document Jan 27, 2023
About Naari Pharma Private Limited
How many FDA Form 483s has Naari Pharma Private Limited received?
FDA Intel has 1 Form 483 on file for Naari Pharma Private Limited; the most recent is dated Jan 27, 2023.
When was Naari Pharma Private Limited last inspected by FDA?
The most recent FDA inspection document on file for Naari Pharma Private Limited is a Form 483 dated Jan 27, 2023, for the site in Rudrapur, India.
What did FDA cite at Naari Pharma Private Limited?
The regulations cited most in the observations on file for Naari Pharma Private Limited are 21 CFR 211.100 (Written procedures; deviations), 2 times.